EUCTR2004-001861-17-NO进行中（未招募）1 期
Treatment Protocol for Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma(EICNHL) - Euro LB 02 protocol
niversity Hospital of Northern Norway. Department of Pediatrics0 个研究点目标入组 600 人开始时间: 2007年2月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •All newly diagnosed patients under the age of 16 years with a T/pre B cell Non Hodgkin lymfoblastic lymphoma will be included. In Norway all patients will be treated at a Pediatric Oncology ward (University Hospital in Oslo/Rikshospitalet or Ullevål Hospital, Haukeland Hospital, St. Olav Hospital or University Hospital in North Norway, Tromso).
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •HIV infection or AIDS.
- •Sever immunodeficiency.
- •Previous organtransplantation.
- •Previous malignancy.
- •Pre-exsiting disease prohibiting chemotherapy as per instructions of this Protocol.
- •Previous chemotherapy or radiotherapy.
- •Previous systemic corticosteroid treatment for more than 8 days within two months before the beginning of the therapy in this Protocol.
研究者
相似试验
进行中（未招募）
不适用
EURO-LB-02. Treatment Protocol for Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL). - EURO-LB 02Multicenter randomised trial conducted in european countries and the five nordic countries on children up to the age of 18 years newly diagnosed with T-cell and and pre -B lymphoblastic lymphoma (T-LBL pre-B-LBL ). The current nordic protocol for treatment of this disease is very similar with new Euro protocol the main difference being to administer dexamethason in the begining of the treatment and not -as to day - 3 months later.EUCTR2004-001861-17-SEOPHO-NHL GRUPP270
进行中（未招募）
不适用
EURO-LB-02. Treatment Protocol for Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL). - EURO-LB 02Multicenter European randomised trial on children up to the age of 18 years newly diagnosed with T-cell and and pre -B lymphoblastic lymphoma (T-LBL pre-B-LBL ). The protocol is similar to the current Nordic and other European protocols. The main difference is whether to administer dexamethasone or prednisolone during the first weeks of induction therapy and whether the total duration of therapy can be shortened from 24 to 18 months for T-cell lymphoma.EUCTR2004-001861-17-DKOPHO-NHL GRUPP270
招募中
3 期
Acute Lymphoblastic Leukemia treatment protocol for children and adolescentRBR-6pmfz8Sociedade Brasileira de Oncologia Pediátrica (SOBOPE)
招募中
2 期
Treatment protocol for adult acute lymphoblastic leukemia (-ALL/MRD2023-)acute lymphoblastic leukemiaJPRN-jRCTs071220071Koichi Akashi210
已完成
2 期
Treatment protocol for adult acute lymphoblastic leukemia -ALL/MRD2014acute lymphoblastic leukemiaJPRN-UMIN000012382Fukuoka Blood & Marrow Transplant Group100